ronacaleret

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2017
02420112017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Rosuvastatin is a widely prescribed antihyperlipidemic which undergoes limited metabolism, but is an in vitro substrate of… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Review
2017
Review
2017
In recent years, an increasing number of clinical drug-drug interactions (DDIs) have been attributed to inhibition of intestinal… (More)
Is this relevant?
2015
2015
Hyperphosphatemia accelerates the progression of chronic kidney diseases. In the present study, the effects of ronacaleret, a… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
CONTEXT Parathyroidectomy in patients with hyperparathyroidism can produce subsequent increases in bone mineral density (BMD… (More)
Is this relevant?
2013
2013
Ronacaleret is an orally-active calcium-sensing receptor (CaSR) antagonist that has the potential for therapeutic utility in the… (More)
Is this relevant?
2012
2012
Intermittent injections of parathyroid hormone have osteoanabolic effects that increase bone mineral density (BMD). Ronacaleret… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
2011
2011
CONTEXT Ronacaleret, a calcium-sensing receptor antagonist that stimulates PTH release from the parathyroid glands, was evaluated… (More)
  • figure 1
  • table 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2011
2011
Ronacaleret therapy increases trabecular volumetric BMD (vBMD) but reduces cortical vBMD in postmenopausal women, report… (More)
Is this relevant?
2011
2011
BACKGROUND Fractures cause significant morbidity, mortality, and use of health care resources. An oral agent that enhances… (More)
Is this relevant?
2011
2011
Acute hypercalcemia inhibits plasma renin activity (PRA). How this occurs is unknown. We hypothesized that acute hypercalcemia… (More)
  • figure 1
  • figure 2
Is this relevant?